Transcatheter Technologies

 Company Summary:
  • Transcatheter Technologies is a medical device company that has developed a full range of transcatheter valve implantation systems for catheter-based heart valve therapy
  • Provides Aortic and Mitral Valve Implantation (TAVI and TMVI)
Transaction Overview:
  • Asset sale to Venus Medtech, a leading heart valve developer in China
Significance of the Transaction:
  • Fuel the continued development of the next-generation technology platform for the treatment of various structural heart diseases in the Chinese market
  • Enhance valve products presence in the global market and expand number of patients that will benefit from the procedure
Healthios Role:
  • Healthios served as exclusive financial adviser to Transcatheter Technologies
  • This transaction highlights Healthios commitment to capital formation in emerging growth companies and our success in completing complex transaction to maximize shareholder interests